Clinical Trials Logo
  1. Home
  2. End-Stage Kidney Disease
  3. NCT05774392
  4. Details
NCT05774392 Clinical Trial

An Observational Study of Patients With Chronic Kidney Disease

End Stage Kidney Disease Clinical Trial

Official title:
An Observational Study of Patients With Chronic Kidney Disease

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05774392
Other study ID # TARGET-KIDNEY
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 2023
Est. completion date December 2037

Study information
Verified date March 2023
Source Target PharmaSolutions, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

TARGET-KIDNEY is an observational research study to conduct a comprehensive review of outcomes for patients with chronic kidney disease (CKD) and end-stage renal disease (ESKD).

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 500000
Est. completion date December 2037
Est. primary completion date December 2037
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Disease Cohort Inclusion Criteria: - Adult* patients at the time of enrollment with a diagnosis of CKD/ESKD by ICD-10 code in the EHR interface Exclusion Criteria: - Death - Manual removal (sponsor or site request) - No EHR interface encounter > 3 years Engaged Cohort Inclusion Criteria: - Adult * patients diagnosed and managed for CKD/ESKD invited to participate - Ability to provide written informed consent Exclusion Criteria: - Patient expressed desire to withdraw consent to complete PROs - Failure to complete PROs within 24 weeks of initial invitation - Greater than 24 months lapse of survey completion after baseline surveys completed - Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Observational
Observational

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Target PharmaSolutions, Inc.

Outcome
Type Measure Description Time frame Safety issue
Primary To characterize the natural history of disease in patients with CKD/ESKD. 20 Years
Primary To assess safety and effectiveness of CKD/ESKD treatments and treatments for complications of either condition 20 Years
Secondary To evaluate provider management practices in the treatment of patients with CKD/ESKD 20 Years
Secondary To evaluate longitudinal and patient reported outcomes in CKD/ESKD 20 Years
Secondary To select and evaluate quality of care measures for patients with CKD/ESKD 20 Years
See also
  Status Clinical Trial Phase
Recruiting NCT04319185 - Assisted Peritoneal Dialysis: A Feasibility Study N/A
Recruiting NCT06056739 - Alio WEAR Study: Long-term Wear of the Alio Platform N/A
Recruiting NCT05311956 - Pain Reduction Using NEurostimulation Study N/A
Active, not recruiting NCT05485961 - Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis Phase 2/Phase 3
Completed NCT02939586 - The Effect of Haemodialysis in Sleep Apnoea N/A
Completed NCT00792454 - Reduction of Mortality Prior to and During the First 90 Days of Dialysis Through a Renal Rehabilitation Program N/A
Recruiting NCT03586518 - Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
Completed NCT02513303 - Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Phase 3
Recruiting NCT05642156 - Hemodynamics in Chronic Hemodialysis Patients Undergoing Isolated Ultrafiltration Compared to Conventional Hemodialysis N/A
Completed NCT01859871 - Evaluation of a Website on Living Kidney Donation for Hispanics N/A
Completed NCT01877863 - The Effect of Intradialytic Exercise on the Functional Capacity of Hemodialysis Patients N/A
Completed NCT00649298 - A Clinical Trial of IntensiVE Dialysis Phase 4
Recruiting NCT05836220 - Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2 Phase 3
Completed NCT04912024 - Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study
Not yet recruiting NCT06356168 - Virtual Reality in End Stage Kidney Disease N/A
Not yet recruiting NCT05558267 - Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease N/A
Completed NCT01530945 - Mapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease N/A
Completed NCT04815850 - Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study
Recruiting NCT05738330 - Symptom Monitoring in Hemodialysis N/A
Completed NCT02475551 - Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation Phase 2